# New Animal Drug Applications; Alfaprostol; Bicyclohexylammonium Fumagillin; N-Butyl Chloride; Competitive Exclusion Culture; Dichlorophene and Toluene; Flurogestone Acetate; Isoflurane; Pyrantel; Tylosin; Tylosin and Sulfamethazine
> **Food and Drug Administration** · Final rule, technical amendment. · Published 2013-03-07 · Effective 2013-03-18 · 78 FR 14667
## Document
- **Document number:** 2013-04999
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 78 FR 14667
- **CFR reference:** 21 CFR 510
- **Publication date:** 2013-03-07
- **Effective date:** 2013-03-18
- **HHS docket:** Docket No. FDA-2012-N-1167
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the withdrawal approval of 19 new animal drug applications (NADAs) and one abbreviated new animal drug application (ANADA). The applications are being withdrawn for lack of compliance with the reporting requirements in an FDA regulation.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2013/03/07/2013-04999/new-animal-drug-applications-alfaprostol-bicyclohexylammonium-fumagillin-n-butyl-chloride)
---
*AI Analytics · CC0 1.0*